Literature DB >> 18054335

The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS.

Takashi Kadowaki1, Toshimasa Yamauchi, Naoto Kubota.   

Abstract

Adiponectin is an abundantly expressed adipokine in adipose tissue and has direct insulin sensitizing activity. A decrease in the circulating levels of adiponectin by interactions between genetic factors and environmental factors causing obesity has been shown to contribute to the development of insulin resistance, type 2 diabetes, metabolic syndrome and atherosclerosis. In addition to its insulin sensitizing actions, adiponectin has central actions in the regulation of energy homeostasis. Adiponectin enhances AMP-activated protein kinase activity in the arcuate hypothalamus via its receptor AdipoR1 to stimulate food intake and decreases energy expenditure. We propose a hypothesis on the physiological role of adiponectin: a starvation gene in the course of evolution by promoting fat storage on facing the loss of adiposity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18054335     DOI: 10.1016/j.febslet.2007.11.070

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  91 in total

1.  An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart.

Authors:  Xiangping Fang; Rengasamy Palanivel; Justin Cresser; Kristin Schram; Riya Ganguly; Farah S L Thong; Joseph Tuinei; Aimin Xu; E Dale Abel; Gary Sweeney
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-08-24       Impact factor: 4.310

Review 2.  Protective vascular and myocardial effects of adiponectin.

Authors:  Barry J Goldstein; Rosario G Scalia; Xin L Ma
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-11-25

3.  A disulfide-bond A oxidoreductase-like protein (DsbA-L) regulates adiponectin multimerization.

Authors:  Meilian Liu; Lijun Zhou; Aimin Xu; Karen S L Lam; Michael D Wetzel; Ruihua Xiang; Jingjing Zhang; Xiaoban Xin; Lily Q Dong; Feng Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-14       Impact factor: 11.205

Review 4.  The bone-adipose axis in obesity and weight loss.

Authors:  J Gómez-Ambrosi; A Rodríguez; V Catalán; G Frühbeck
Journal:  Obes Surg       Date:  2008-06-19       Impact factor: 4.129

5.  Impact of adiponectin deficiency on pulmonary responses to acute ozone exposure in mice.

Authors:  Ming Zhu; Christopher Hug; David I Kasahara; Richard A Johnston; Alison S Williams; Norah G Verbout; Huiqing Si; Jordan Jastrab; Amit Srivastava; Erin S Williams; Barbara Ranscht; Stephanie A Shore
Journal:  Am J Respir Cell Mol Biol       Date:  2009-11-13       Impact factor: 6.914

Review 6.  What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?

Authors:  Carmine Finelli; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

Review 7.  APPL1: role in adiponectin signaling and beyond.

Authors:  Sathyaseelan S Deepa; Lily Q Dong
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-14       Impact factor: 4.310

Review 8.  Adipocytokines and the metabolic complications of obesity.

Authors:  Neda Rasouli; Philip A Kern
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

9.  Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 months.

Authors:  Inga-Lill Engvall; Birgitta Tengstrand; Kerstin Brismar; Ingiäld Hafström
Journal:  Arthritis Res Ther       Date:  2010-10-21       Impact factor: 5.156

10.  Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008.

Authors:  Markku Laakso
Journal:  Diabetes Care       Date:  2010-02       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.